← Open Payments lookup

JAMAL SALEH: Open Payments

NPI 1306112776 · DETROIT, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,242 in 94 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $395 · 2025 $2,242

Food & beverage: $2,019Education: $223
CompanyPaymentsAmount
E.R. Squibb & Sons, L.L.C.22$521
Janssen Pharmaceuticals, Inc15$334
Teva Pharmaceuticals USA, Inc.8$324
Otsuka America Pharmaceutical, Inc.19$299
Luye Pharma (USA) Ltd.8$169
Alkermes, Inc.6$147
Neurocrine BioSciences, Inc.1$124
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)5$100
Vanda Pharmaceuticals Inc.3$88
Lundbeck LLC4$82

Products named: COBENFY, INVEGA SUSTENNA, ABILIFY MAINTENA, REXULTI, ERZOFRI EXTENDED-RELEASE, ARISTADA, INGREZZA, UZEDY.

Industry payments across MI — which companies pay providers there.